NY Blood Thinner Injury Lawyers | Eliquis®, Pradaxa®, and Xarelto®

Claims have been made that Pfizer and Bristol-Myres Squibb failed to disclose material information to the Food and Drug Administration (FDA) concerning these drugs, commonly known as “Eliquis®”.  Eliquis® is marketed as an anticoagulant, meaning that it decreases the process for blood clotting through inhibiting Factor Xa.

Because there has been no known reversal agent which would allow for normal blood clotting, patients using Eliquis® may be at a high risk of bleeding to death during surgery, as well as other complications that may arise when blood does not clot normally.  We are part of the Blood Thinner Litigation Group, which is devoted to helping those injured, and the families who have lost a loved one, due to the use of Eliquis®, Pradaxa®, and Xarelto®.

Click Here to see our
Blood Thinner Litigation Website

We invite you to see the website for the Blood Thinner Litigation Group, and to call us to learn how we can help.  We offer a free consultation, and there are no fees for us unless and until we recover for you.

103 W. Seneca Street, Suite 301
Ithaca, NY 14850
Telephone: (607) 272-5590
Fax: (607) 272-5594

By submitting this form Friedlander & Friedlander, P.C. will take no action to protect your interests. Submission of this form does not estalish an attorney-client privilege. Please do not submit any confidential information through this form.